Top

Optie A:

Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
Optie B:

Deel de link per e-mail
Link delen

vorige artikel The Relationship Between the Childhood Autism R...

volgende artikel Brief Report: Early VEPs to Pattern-Reversal in...

Tip

Swipe om te navigeren naar een ander artikel

27-07-2016 | Brief Report | Uitgave 10/2016

Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network

Tijdschrift:: Journal of Autism and Developmental Disorders > Uitgave 10/2016

Auteurs:: Deborah A. Bilder, Amanda V. Bakian, David A. Stevenson, Paul S. Carbone, Christopher Cunniff, Alyson B. Goodman, William M. McMahon, Nicole P. Fisher, David Viskochil

» Toegang tot de volledige tekst krijgen

Abstract

Neurofibromatosis type 1 (NF1) is an inherited neurocutaneous disorder associated with neurodevelopmental disorders including autism spectrum disorder (ASD). The frequency of ASD/NF1 co-occurrence has been subject to debate since the 1980s. This relationship was investigated in a large population-based sample of 8-year-old children identified with ASD (N = 12,271) by the Centers for Disease Control and Prevention’s Autism and Developmental Disabilities Monitoring (ADDM) Network. Twenty-two (1-in-558) children with ASD had diagnosed NF1, exceeding NF1 general population estimates by four to five fold. Children with ASD/NF1 versus ASD without NF1 were significantly less likely to receive a community-based ASD diagnosis (p = 0.04) and understand non-verbal communication (p = 0.001). These findings underscore the importance of including social-communication ability among relevant developmental concerns in children with NF1.

Log in om toegang te krijgen

Hier inloggen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Met BSL Psychologie Totaal blijft u als professional steeds op de hoogte van de nieuwste ontwikkelingen binnen uw vak. Met het online abonnement heeft u toegang tot een groot aantal boeken, protocollen, vaktijdschriften en e-learnings op het gebied van psychologie en psychiatrie. Zo kunt u op uw gemak en wanneer het u het beste uitkomt verdiepen in uw vakgebied.

Meer informatie

American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington: American Psychiatric Association.

American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington: American Psychiatric Association.

American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington: American Psychiatric Association.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators. (2007). Prevalence of autism spectrum disorders–autism and developmental disabilities monitoring network, 14 sites, United States, 2002. Morbidity and Mortality Weekly Report, 56, 12–28.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators. (2009). Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, United States, 2006. Morbidity and Mortality Weekly Report, 58(SS10), 1–20.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators. (2012). Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008. Morbidity and Mortality Weekly Report, 61(3), 1–19.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators. (2014). Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. Morbidity and Mortality Weekly Report, 63(2), 1–21.

Brei, N. G., Klein-Tasman, B. P., Schwarz, N. G., & Casnar, C. L. (2014). Language in young children with neurofibromatosis-1: Relations to functional communication, attention, and social functioning. Research in Developmental Disabilities, 35, 2495–2504. CrossRefPubMed

DeBella, K., Szudek, J., & Friedman, J. M. (2000). Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics, 105, 608–614. CrossRefPubMed

Dilts, C. V., Carey, J. C., Kircher, J. C., Hoffman, R. O., Creel, D., Ward, K., et al. (1996). Children and adolescents with neurofibromatosis 1: A behavioral phenotype. Journal of Developmental and Behavioral Pediatrics, 17, 229–239. CrossRefPubMed

Fombonne, E., Du Mazaubrun, C., Cans, C., & Grandjean, H. (1997). Autism and associated medical disorders in a French epidemiological survey. Journal of the American Academy of Child and Adolescent Psychiatry, 36(11), 1569–1591.

Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, E. G., et al. (2013a). Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics, 132, e1642–e1648. CrossRefPubMed

Garg, S., Lehtonen, A., Huson, S. M., Emsley, R., Trump, D., Evans, D. G., et al. (2013b). Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study. Developmental Medicine and Child Neurology, 55, 139–145. CrossRefPubMed

Gillberg, C., & Forsell, C. (1984). Childhood psychosis and neurofibromatosis—more than a coincidence? Journal of Autism and Developmental Disorders, 14(1), 1–8. CrossRefPubMed

Hersh, J. H., & Committee on Genetics. (2008). Health supervision for children with neurofibromatosis. Pediatrics, 121, 633–642. CrossRef

Huijbregts, S. C. J., & de Sonneville, L. M. J. (2011). Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1? Behavior Genetics, 41, 430–436. CrossRefPubMed

Hyman, S. L., Arthur, S. E., & North, K. N. (2006). Learning disabilities in children with neurofibromatosis type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine and Child Neurology, 48, 973–977. CrossRefPubMed

Hyman, S. L., Shores, A., & North, K. N. (2005). The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology, 65, 1037–1044. CrossRefPubMed

Lammert, M., Friedman, J. M., Kluwe, L., & Mautner, V. F. (2005). Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Archives of Dermatology, 141, 71–74. CrossRefPubMed

Maenner, M. J., Rice, C. E., Arneson, C. L., Cunniff, C., Schieve, L. A., Carpenter, L. A., et al. (2014). Potential impact of DSM-5 criteria on autism spectrum disorder prevalence estimates. Journal of the American Medical Association Psychiatry, 71(3), 292–300. PubMedPubMedCentral

McKeever, K., Shepherd, C. W., Crawford, H., & Morrison, P. J. (2008). An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age. Ulster Medical Journal, 77, 160–163. PubMedPubMedCentral

Miller, J. S., Bilder, D., Farley, M., Coon, H., Pinborough-Zimmerman, J., Jenson, W., et al. (2013). Autism spectrum disorders reclassified: A second look at the 1980’s Utah/UCLA autism epidemiologic study. Journal of Autism and Developmental Disorders, 43(1), 200–210. CrossRefPubMedPubMedCentral

Mouridsen, S. E., Andersen, L. B., Sorensen, S. A., Rich, B., & Isager, T. (1992). Neurofibromatosis in infantile autism and other types of childhood psychoses. Acta Paedopsychiatrica, 55(1), 15–18. PubMed

National Center for Health Statistics (2002). Classification of diseases and injuries. Retrieved from ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD-9/ucod.txt.

National Institutes of Health Consensus Development Conference. (1988). Neurofibromatosis conference statement. Archives of Neurology, 45, 575–578. CrossRef

Ozonoff, S. (1999). Cognitive impairment in neurofibromatosis type 1. American Journal of Medical Genetics, 89, 45–52. CrossRefPubMed

Plasschaert, E., Descheemaeker, M., Van Eylen, L., Noens, I., Steyaert, J., & Legius, E. (2014). Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 168(1), 72–80. CrossRef

Statistical Analysis System (Version 9.3). (2011) [Computer software]. Cary, NC: SAS Institute Inc.

Tinker, J., Carbone, P. S., Viskochil, D., Mathiesen, A., Ma, K. N., & Stevenson, D. A. (2014). Screening children with neurofibromatosis type 1 for autism spectrum disorder. American Journal of Medical Genetics. Part A, 164(7), 1706–1712. CrossRef

US Department of Health and Human Services. (2009) Code of federal regulations. Title 45. Public Welfare CFR 46. Retrieved from http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html.

van Eeghen, A. M., Pulsifer, M. B., Merker, V. L., Neumeyer, A. M., van Eeghen, E. E., Thibert, R. L., et al. (2012). Understanding relationships between autism, intelligence, and epilepsy: A cross-disorder approach. Developmental Medicine and Child Neurology, 55(2), 146–153. CrossRefPubMed

Volkmar, F. R., Bregman, J., Cohen, D. J., & Cicchetti, D. V. (1988). DSM-III and DSM-III-R diagnoses of autism. American Journal of Psychiatry, 145, 1404–1408. CrossRefPubMed

Walsh, K. S., Velez, J. I., Kardel, P. G., Imas, D. M., Muenke, M., Packer, R. J., et al. (2013). Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Developmental Medicine and Child Neurology, 55, 131–138. CrossRefPubMed

Williams, P. G., & Hersh, J. H. (1998). Brief report: the association of neurofibromatosis type 1 and autism. Journal of Autism and Developmental Disorders, 28(6), 567–571. CrossRefPubMed

Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. Journal of the American Medical Association, 289, 49–55. PubMed

Titel: Brief Report: The Prevalence of Neurofibromatosis Type 1 among Children with Autism Spectrum Disorder Identified by the Autism and Developmental Disabilities Monitoring Network
Auteurs:: Deborah A. Bilder
Amanda V. Bakian
David A. Stevenson
Paul S. Carbone
Christopher Cunniff
Alyson B. Goodman
William M. McMahon
Nicole P. Fisher
David Viskochil
Publicatiedatum: 27-07-2016
DOI: https://doi.org/10.1007/s10803-016-2877-3
Uitgeverij: Springer US
Tijdschrift: Journal of Autism and Developmental Disorders
Uitgave 10/2016
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Tip

Swipe om te navigeren naar een ander artikel

Abstract

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Andere artikelen Uitgave 10/2016

Dual Cognitive and Biological Correlates of Anxiety in Autism Spectrum Disorders

The Role of Attention in Somatosensory Processing: A Multi-trait, Multi-method Analysis

The Relationship Between the Childhood Autism Rating Scale: Second Edition and Clinical Diagnosis Utilizing the DSM-IV-TR and the DSM-5

Brief Report: The Effects of Equine-Assisted Activities on the Social Functioning in Children and Adolescents with Autism Spectrum Disorder

Proband Mental Health Difficulties and Parental Stress Predict Mental Health in Toddlers at High-Risk for Autism Spectrum Disorders

Relationship Between Executive Functioning and Symptoms of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in 6–8 Year Old Children